AMRN Q2 2025 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$310M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$73M+7.7% YoY

Gross Profit

$50M69.2% margin

Operating Income

-$16M-22.0% margin

Net Income

-$14M-19.4% margin

EPS (Diluted)

$-0.68

QoQ Revenue Growth

+73.1%

Cash Flow

Operating Cash Flow

$17M

Free Cash Flow

$17M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$670M

Total Liabilities

$205M

Stockholders' Equity

$465M

Cash & Equivalents

$148M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$73M	$68M	+7.7%
Gross Profit	$50M	$42M	+19.8%
Operating Income	-$16M	-$524,587	-2947.2%
Net Income	-$14M	$2M	-1027.9%

Revenue Segments

Product

$47M64%

Licensing And Royalty

$26M36%

Geographic Segments

UNITED STATES

$37M85%

Europe

$7M15%